News
The main problem is that most vector production technologies were developed for the lab, rather than to support industrial ...
The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...
Strategic appointments advance Addgene’s growth and market expansion strategyWATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- Addgene, an organization empowering discovery by providing scientists ...
How to design and launch a successful Clinical Trial Manufacturing.
Researchers have developed novel lymph-node-inspired hydrogels that significantly enhance the activation, gene expression, ...
Gene therapy, a technique that is revolutionizing the treatment of multiple genetic conditions, including eye and muscle ...
Patient associations are shaping trials, asking hard questions, and demanding realistic timelines for treatment delivery.
A new article argues dystrophin immunogenicity is an under-examined issue in the treatment of Duchenne muscular dystrophy.
The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...
Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results